|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 92, 636-648, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
BS Allen, GD Buckberg, M Schwaiger, L Yeatman, J Tillisch, N Kawata, J Messenger and C Lee
This study tests the hypothesis that failure of "successful" streptokinase
with and without angioplasty to restore regional wall motion in patients
with acute coronary occlusion is due to reperfusion injury that can be
avoided in the surgical setting by control of the conditions of reperfusion
and the composition of the reperfusate. Of 31 consecutive patients
undergoing emergency coronary revascularization, 21 patients were
reperfused medically with normal blood (streptokinase with or without
angioplasty) following 4.5 +/- 0.4 hours of coronary occlusion in the
coronary catheterization laboratory. Surgical reperfusion in 10 patients
was with aspartate-glutamate-enriched blood cardioplegic solution during
coronary artery bypass grafting after 8.5 +/- 0.5 hours (7.2 to 11.4 hours)
of acute coronary occlusion. Hemodynamic instability was present in 5 of 10
surgical patients before operation and resulted from coronary occlusion,
whereas 7 to 21 previously stable medical patients became unstable
hemodynamically following revascularization with normal blood. Surgical
patients evolved fewer electrocardiographically determined infarctions
(7/10 versus 21/21, p less than 0.05), had fewer reperfusion ventricular
arrhythmias (0/10 versus 9/21, p less than 0.05), had somewhat better
global ejection fractions (47% versus 41%), and had shorter hospitalization
times (8.3 versus 10.7 days, p less than 0.05); in addition, they all
showed significant segmental contractility at discharge (10/10 versus 2/21,
p less than 0.05), despite delay of revascularization up to 11 hours. No
deaths occurred. These studies imply that acute coronary occlusion is
treated best by control of the conditions of reperfusion and the
composition of the reperfusate.
ARTICLES
Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion [published erratum appears in J Thorac Cardiovasc Surg 1987 Jan;93(1):140]
This article has been cited by other articles:
![]() |
I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text] |
||||
![]() |
G. D. Buckberg Stroke and extra-cardiac perfusion: new vantage points in brain protection Eur. J. Cardiothorac. Surg., December 1, 2004; 26(Suppl_1): S62 - S67. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658. [Full Text] |
||||
![]() |
C. Schlensak, T. Doenst, J. Kobba, and F. Beyersdorf Protection of acutely ischemic myocardium by controlled reperfusion Ann. Thorac. Surg., November 1, 1999; 68(5): 1967 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tomasco, A. Cappiello, R. Fiorilli, A. Leccese, R. Lupino, A. Romiti, and U. F. Tesler Surgical Revascularization for Acute Coronary Insufficiency: Analysis of Risk Factors for Hospital Mortality Ann. Thorac. Surg., September 1, 1997; 64(3): 678 - 683. [Abstract] [Full Text] |
||||
![]() |
E. R. Rosenkranz Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [Full Text] |
||||
![]() |
F. Beyersdorf Protection of Evolving Myocardial Infarction and Failed PTCA Ann. Thorac. Surg., September 1, 1995; 60(3): 833 - 838. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |